Starling Oncology (STLN)

Starling Oncology (STLN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• STLN last traded at $4.50, 12.50% on the day.
• Starling Oncology: market cap $449.92M, revenue $620.45M over the last four quarters.

Updated 2026-11-11 00:46 UTC